Quest Diagnostics (DGX) Institutional Ownership
13F filers reported holding 95.9% of Quest Diagnostics (DGX) shares as of Jun 30, 2026, across 1,119 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 95.9%
- Jun 30, 2026
- 13F filers
- 1,119
- quarter ended Jun 30, 2026
- 13F value
- $22.3B
- 105.5M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Acquired · Option exercise | 4,274 | $127.73 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Disposed · Open-market sale | 4,274 | $257.34 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Acquired · Option exercise | 6,793 | $127.81 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Disposed · Open-market sale | 6,793 | $257.34 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Disposed · Open-market sale | 650 | $257.34 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Disposed · Option exercise | 4,274Non-Qualifed Stock Option (right to buy) | $127.73 | ↗ |
| Nov 9, 2026 | Plewman Patrick | SVP for Diagnostic Services | Disposed · Option exercise | 6,793Non-Qualifed Stock Option (right to buy) | $127.81 | ↗ |
| Nov 3, 2026 | Ramachandran Subu | SVP, Regional Businesses | Acquired · Grant / award | 352 | — | ↗ |
| Nov 3, 2026 | Ramachandran Subu | SVP, Regional Businesses | Acquired · Grant / award | 1,386Non-Qualifed Stock Option (right to buy) | — | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Acquired · Grant / award | 4,827 | — | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Acquired · Option exercise | 22,105 | $121.81 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 3,818 | $245.45 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 5,990 | $246.26 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 1,151 | $246.98 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 2,358 | $248.38 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 3,004 | $249.40 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 2,877 | $250.49 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Open-market sale | 2,907 | $251.24 | ↗ |
| Nov 3, 2026 | Doherty Catherine T. | Executive Vice President | Disposed · Option exercise | 22,105Non-Qualifed Stock Option (right to buy) | $121.81 | ↗ |
| Nov 3, 2026 | DELANEY MARK E | SVP & Chief Commercial Officer | Acquired · Grant / award | 2,615 | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Quest Diagnostics do institutions hold?
13F filers reported holding 95.9% of Quest Diagnostics' shares as of Jun 30, 2026, across 1,119 filers.
How many 13F filers hold Quest Diagnostics?
Quest Diagnostics was held by 1,119 13F filers as of Jun 30, 2026.
Not investment advice.

